Han Yu Pharmaceutical and MCG Pharma signed a product authorization agreement to jointly develop the pharmaceutical market in Turkey.

On April 10th, HanYu Pharmaceutical held a signing ceremony with the well-known Turkish pharmaceutical and health company MCG Pharma la Sanayi ve Ticaret Limited irketi for the external authorization of Liraglutide Injection and Semaglutide Injection, marking the successful entry of HanYu Pharmaceutical's core products Liraglutide and Semaglutide into the Turkish market and becoming a key step in the company's internationalization strategy layout in the Middle East region.